Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CDXS
#3293
Codexis, Inc.
1.0
1
-5.61%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-5.61%
Monthly Change
-30.82%
6 month change
-62.31%
Year Change
-71.14%
Previous Close
1.0
7
Open
1.0
1
Bid
Ask
Low
1.0
1
High
1.0
1
Volume
54
Markets
US Stock Market
Healthcare
CDXS
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Codexis Inc
Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.
News
Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss, Misses Revenue Estimates
Beam Therapeutics Inc. (BEAM) Reports Q4 Loss, Beats Revenue Estimates
Incyte (INCY) Q4 Earnings Lag Estimates
Codexis CSO Stefan Lutz sells $7949 in shares
Opaleye management sells Codexis (CDXS) shares for $1.87 million
Opaleye management sells Codexis (CDXS) shares worth $877,846
Down 30% in 4 Weeks, Here's Why You Should You Buy the Dip in Codexis (CDXS)
Codexis (CDXS) Reports Q3 Loss, Misses Revenue Estimates
Airbnb, Monster Beverage, Take-Two and more set to report earnings Thursday
EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Misses Revenue Estimates
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Beats Revenue Estimates
Codexis at Cantor Global Healthcare: Scaling siRNA Production